These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 27005572)

  • 1. Mycobacterium tuberculosis whole genome sequencing and protein structure modelling provides insights into anti-tuberculosis drug resistance.
    Phelan J; Coll F; McNerney R; Ascher DB; Pires DE; Furnham N; Coeck N; Hill-Cawthorne GA; Nair MB; Mallard K; Ramsay A; Campino S; Hibberd ML; Pain A; Rigouts L; Clark TG
    BMC Med; 2016 Mar; 14():31. PubMed ID: 27005572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole genome sequencing of drug resistant Mycobacterium tuberculosis isolates from a high burden tuberculosis region of North West Pakistan.
    Jabbar A; Phelan JE; de Sessions PF; Khan TA; Rahman H; Khan SN; Cantillon DM; Wildner LM; Ali S; Campino S; Waddell SJ; Clark TG
    Sci Rep; 2019 Oct; 9(1):14996. PubMed ID: 31628383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB.
    Al-Mutairi NM; Ahmad S; Mokaddas EM
    Eur J Med Res; 2019 Dec; 24(1):38. PubMed ID: 31806020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
    Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
    BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in rpoB and katG genes of multidrug resistant mycobacterium tuberculosis undetectable using genotyping diagnostic methods.
    Takawira FT; Mandishora RSD; Dhlamini Z; Munemo E; Stray-Pedersen B
    Pan Afr Med J; 2017; 27():145. PubMed ID: 28904673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of novel
    Valafar F; Ramirez-Busby SM; Torres J; Paul LV; Rodwell TC; Victor TC; Rodrigues C; Gler MT; Crudu V; Catanzaro T
    Int J Mycobacteriol; 2015 Mar; 4(Suppl 1):51-52. PubMed ID: 27695670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-Genome Sequencing for Resistance Level Prediction in Multidrug-Resistant Tuberculosis.
    Li J; Yang T; Hong C; Yang Z; Wu L; Gao Q; Yang H; Tan W
    Microbiol Spectr; 2022 Jun; 10(3):e0271421. PubMed ID: 35658579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-genome sequence analysis and comparisons between drug-resistance mutations and minimum inhibitory concentrations of Mycobacterium tuberculosis isolates causing M/XDR-TB.
    Nonghanphithak D; Kaewprasert O; Chaiyachat P; Reechaipichitkul W; Chaiprasert A; Faksri K
    PLoS One; 2020; 15(12):e0244829. PubMed ID: 33382836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of next-generation sequencing to detect variants of drug-resistant Mycobacterium tuberculosis: genotype-phenotype correlation.
    Ko DH; Lee EJ; Lee SK; Kim HS; Shin SY; Hyun J; Kim JS; Song W; Kim HS
    Ann Clin Microbiol Antimicrob; 2019 Jan; 18(1):2. PubMed ID: 30606210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic.
    Isakova J; Sovkhozova N; Vinnikov D; Goncharova Z; Talaibekova E; Aldasheva N; Aldashev A
    BMC Microbiol; 2018 Mar; 18(1):22. PubMed ID: 29566660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlating genetic mutations with isoniazid phenotypic levels of resistance in Mycobacterium tuberculosis isolates from patients with drug-resistant tuberculosis in a high burden setting.
    Pinhata JMW; Brandao AP; Mendes FF; Rabello MCDS; Ferrazoli L; de Oliveira RS
    Eur J Clin Microbiol Infect Dis; 2021 Dec; 40(12):2551-2561. PubMed ID: 34297229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal whole genome analysis of pre and post drug treatment Mycobacterium tuberculosis isolates reveals progressive steps to drug resistance.
    Datta G; Nieto LM; Davidson RM; Mehaffy C; Pederson C; Dobos KM; Strong M
    Tuberculosis (Edinb); 2016 May; 98():50-5. PubMed ID: 27156618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoniazid and Rifampin-Resistance Mutations Associated With Resistance to Second-Line Drugs and With Sputum Culture Conversion.
    Click ES; Kurbatova EV; Alexander H; Dalton TL; Chen MP; Posey JE; Ershova J; Cegielski JP
    J Infect Dis; 2020 Jun; 221(12):2072-2082. PubMed ID: 32002554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of multidrug resistance in Mycobacterium tuberculosis.
    Sekiguchi J; Miyoshi-Akiyama T; Augustynowicz-Kopeć E; Zwolska Z; Kirikae F; Toyota E; Kobayashi I; Morita K; Kudo K; Kato S; Kuratsuji T; Mori T; Kirikae T
    J Clin Microbiol; 2007 Jan; 45(1):179-92. PubMed ID: 17108078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome sequencing of Mycobacterium tuberculosis clinical isolates revealed isoniazid resistance mechanisms undetected by conventional molecular methods.
    Laurent S; Zakham F; Bertelli C; Merz L; Nicod L; Mazza-Stalder J; Greub G; Jaton K; Opota O
    Int J Antimicrob Agents; 2020 Aug; 56(2):106068. PubMed ID: 32603684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of mutations associated with isoniazid resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
    Jagielski T; Bakuła Z; Roeske K; Kamiński M; Napiórkowska A; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J
    J Antimicrob Chemother; 2014 Sep; 69(9):2369-75. PubMed ID: 24855126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-genome sequencing of
    Wang L; Yang J; Chen L; Wang W; Yu F; Xiong H
    Epidemiol Infect; 2022 Jan; 150():e22. PubMed ID: 35086603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethionamide cross- and co-resistance in children with isoniazid-resistant tuberculosis.
    Schaaf HS; Victor TC; Venter A; Brittle W; Jordaan AM; Hesseling AC; Marais BJ; van Helden PD; Donald PR
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1355-9. PubMed ID: 19861006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic mutations associated with isoniazid resistance in Mycobacterium tuberculosis: a systematic review.
    Seifert M; Catanzaro D; Catanzaro A; Rodwell TC
    PLoS One; 2015; 10(3):e0119628. PubMed ID: 25799046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole Genome Sequencing Investigation of a Tuberculosis Outbreak in Port-au-Prince, Haiti Caused by a Strain with a "Low-Level" rpoB Mutation L511P - Insights into a Mechanism of Resistance Escalation.
    Ocheretina O; Shen L; Escuyer VE; Mabou MM; Royal-Mardi G; Collins SE; Pape JW; Fitzgerald DW
    PLoS One; 2015; 10(6):e0129207. PubMed ID: 26039194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.